Effects of a New Low-Dose Triple Single-Pill Antihypertensive Combination on Electrolytes and Creatinine Compared to Placebo and Dual Therapies
by Prateek Chopra | June 9, 2026 | Cardiology Conferences | ESH 2026 Therapeutic Context: Triple SPCs containing three low-dose antihypertensive agents are emerging as a promising strategy for improving BP control. GMRx2 (telmisartan/amlodipine/indapamide; WIDAPLIK) was recently FDA-approved, and its effects on serum electrolytes and renal function were evaluated against placebo and dual-combination therapies. Study Design: Placebo-Controlled Trial Findings: Active-Controlled Trial […]